Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse model.
Saved in:
| Title: | Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse model. |
|---|---|
| Authors: | Furuya H; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA. hideki.furuya@cshs.org.; Department of Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, Honolulu, HI, 96822, USA. hideki.furuya@cshs.org.; Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Davis Research Building, 110 N. George Burns Road, Los Angeles, CA, 90048, USA. hideki.furuya@cshs.org., Hayashi K; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.; Department of Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Shimizu Y; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.; Department of Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, Honolulu, HI, 96822, USA., Kim N; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA., Tsukikawa Y; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA., Chen R; Department of Computer Science and Engineering, State University of New York at Buffalo, Buffalo, NY, 14203, USA., Sun Y; Department of Computer Science and Engineering, State University of New York at Buffalo, Buffalo, NY, 14203, USA.; Department of Microbiology and Immunology, State University of New York at Buffalo, Buffalo, NY, 14203, USA., Chan OTM; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA., Pagano I; Cancer Prevention in Pacific Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA., Peres R; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA., Hokutan K; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.; Department of Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, Honolulu, HI, 96822, USA., Igari F; Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Davis Research Building, 110 N. George Burns Road, Los Angeles, CA, 90048, USA., Chan KS; Department of Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Rosser CJ; Clinical & Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, 96813, USA.; Department of Molecular Biosciences and Bioengineering, University of Hawaii at Manoa, Honolulu, HI, 96822, USA.; Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Davis Research Building, 110 N. George Burns Road, Los Angeles, CA, 90048, USA. |
| Source: | Journal of translational medicine [J Transl Med] 2020 Feb 05; Vol. 18 (1), pp. 57. Date of Electronic Publication: 2020 Feb 05. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1479-5876 |
|---|---|
| DOI: | 10.1186/s12967-020-02239-6 |
